Exciting news long awaited by so many! Not everyone will qualify, but it's at least a start for those who depend on insulin to keep them alive.
"On March 24, Medicare announced that it will now reimburse “therapeutic continuous glucose monitoring” (CGM) devices for people with type 1 or type 2 diabetes on intensive insulin therapy (“MDI” – multiple daily injections – or a pump). This milestone is a big deal because it establishes reimbursement for Dexcom’s G5 CGM, the only “therapeutic CGM” – meaning it has FDA approval for making diabetes decisions without a confirmatory finger stick – currently available in the US."
Here is the full article: https://diatribe.org/medicare-reimbursement-d...
Next Discussion: SGLT-2 Inhibitors May Help Your Heart »